Collectively, these data provide evidence that TAK1 inhibition alters DCs such that they remain immature for longer periods, and exhibit lower T cell stimulating capability, leading to immunosuppression in T1DM. The gene discussed is MAP3K7; the disease is type 1 diabetes mellitus.